Viroclear-Dalsiclear (Sofosbuvir - Daclatasvir)
Viroclear-Dalsiclear is a modern drug against the hepatitis C virus. It is a generic drug and is produced in India by analogy with the original drug based on Sofosbuvir and Daclatasvir.
The active substance of the drug Viroclear-Dalsiclear - Sofosbuvir and Daclatasvir. Generic refers to polymerase inhibitors and acts by suppressing the replication of ribonucleic acid, which is necessary for the hepatitis C virus for development and reproduction. Thus, it is necessary to buy Viroclear-Dalsiclear for the treatment of 1, 2, 3, 4 genotypes of hepatitis C. The drug was tested in clinical trials. The reaction of the organism to the active substance of the agent has shown that in most cases the drug promotes healing. The exact numbers are as follows.
Patients who had not previously received any treatment recovered after 8 weeks in 95% of cases.
Further treatment for up to 12 weeks has contributed to recovery in 97% of cases.
Patients who had previously been treated with other antiviral agents recovered after 12 weeks of taking Viroclear-Dalsiclear in 95% of cases.
Viroclear-Dalsiclear is prescribed a course depending on the source data (the patient's condition, previous treatment, the presence of chronic diseases, etc.). Doctors recommend to buy Sofosbuvir and Daclatasvir, and not Interferon, which was appointed before the appearance on the market of a new drug. Compared to him, Viroclear-Dalsiclear contributes to recovery much faster and with fewer side effects.
Viroclear-Dalsiclear is a new generation of modern medicine. It belongs to the NS5B polymerase inhibitor and inhibits the further development of the virus in the body. Due to the effect of the drug, the patient's liver is damaged to a lesser extent and in 8-12 weeks it completely gets rid of the hepatitis C virus 1-4 genotypes.
FORM OF ISSUE
The price of Viroclear-Dalsiclear is indicated for the package, which contains 28 oval-shaped tablets. Each tablet contains 400 mg of Sofosbuvir and Daclatasvir.
INDICATIONS FOR USE
Reception of Viroclear-Dalsiclear is prescribed against hepatitis C in chronic and normal form. In the process of treatment it is necessary to combine Sofosbuvir and Daclatasvir with other drugs against hepatitis C. Viroclear-Dalsiclear is not suitable for monotherapy. Comprehensive treatment helps to more effectively suppress the virus and achieve recovery much faster. Additional drugs should be selected by the attending physician taking into account the patient’s condition and associated diseases, for example, liver cirrhosis.
METHOD OF ADMINISTRATION AND DOSES
The daily dose is 400 mg of Sofosbuvir and Daclatasvir, i.e. corresponds to one tablet. The tablet must be swallowed whole and drink plenty of water. Do not exceed the standard dose, because This can lead to negative consequences for human health. If the next pill has been missed, it is necessary to take it within 18 hours and after that the next dose at the usual time. After 18 hours, you should use only one pill and then follow the usual schedule. The duration of treatment is determined by the doctor. Most often, the agent is prescribed for 8-12 weeks. Price Sofosbuvir and Daclatasvir allows you to take the drug for a long time.
Viroclear-Dalsiclear causes side effects only in rare cases. Basically, the drug is well tolerated and does not cause concern to the patient. In some cases, the following symptoms are observed: dizziness, nausea, fatigue, insomnia, arrhythmia. It is important to take Viroclear-Dalsiclear at the same time and avoid overdosing. This can reduce the severity of unpleasant symptoms.
CONTRAINDICATIONS FOR USE
Sofosbuvir and Daclatasvir is contraindicated during pregnancy, during the feeding period, up to 18 years and if you are allergic to the components of the product. If the state of health has deteriorated sharply, it is necessary to inform the attending physician immediately.
INTERACTION WITH OTHER PREPARATIONS
Viroclear-Dalsiclear Sofosbuvir and Daclatasvir is incompatible with rifamycin, phenytoin, carbamacine, hunter, telaprevir, boceprevir. Prohibited simultaneous use with drugs against arrhythmias.
Tablets should be stored at temperatures up to 30 ° C.
- Trade name Viroclear-Dalsiclear
- Substance Sofosbuvir - Daclatasvir
- Manufacturer Abbott India Ltd
- Packaging 28 Tablet
- Country of origin India